Black Rock Inc. Bei Gene, Ltd. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Black Rock Inc. holds 948,667 shares of BGNE stock, worth $141 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

948,667

Previous 854,876 10.97%

Holding current value

$141 Million

Previous $154 Million 3.78%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$141.8 - $181.47 $13.3 Million - $17 Million	93,791 Added 10.97%	948,667 $148 Million
Q4 2023 Feb 13, 2024	BUY	$158.67 - $201.58 $7.8 Million - $9.91 Million	49,182 Added 6.1%	854,876 $154 Million
Q3 2023 Nov 13, 2023	SELL	$179.87 - $225.13 $11.3 Million - $14.2 Million	-63,063 Reduced 7.26%	805,694 $145 Million
Q2 2023 Aug 11, 2023	BUY	$178.3 - $266.78 $29.1 Million - $43.5 Million	162,949 Added 23.09%	868,757 $155 Million
Q1 2023 May 12, 2023	BUY	$215.53 - $274.5 $104,316 - $132,858	484 Added 0.07%	705,808 $152 Million

Q4 2022 Feb 13, 2023	SELL	$125.51 - $229.3 $262 Million - $478 Million	-2,083,577 Reduced 74.71%	705,324 $155 Million
Q3 2022 Nov 14, 2022	SELL	$131.8 - $202.24 $9.63 Million - $14.8 Million	-73,028 Reduced 2.55%	2,788,901 $376 Million
Q2 2022 Aug 12, 2022	BUY	$121.11 - $216.05 $19.7 Million - $35.1 Million	162,485 Added 6.02%	2,861,929 $463 Million
Q1 2022 May 12, 2022	BUY	$146.52 - $269.56 $14.4 Million - $26.5 Million	98,316 Added 3.78%	2,699,444 $509 Million
Q4 2021 Feb 10, 2022	SELL	$248.56 - $389.34 $7.06 Million - $11.1 Million	-28,414 Reduced 1.08%	2,601,128 $705 Million
Q3 2021 Nov 09, 2021	BUY	$249.6 - $403.14 $24.8 Million - $40 Million	99,215 Added 3.92%	2,629,542 $955 Million
Q2 2021 Aug 11, 2021	BUY	$292.75 - $367.01 $741 Million - $929 Million	2,530,327 New	2,530,327 $868 Million

Others Institutions Holding BGNE

# of Institutions

216

Shares Held

45.1M

Call Options Held

76.5K

Put Options Held

72.3K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $15.4B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account